Literature DB >> 21721400

The influence of botulinum toxin type A (BTX) on the immunohistochemical characteristics of noradrenergic and cholinergic nerve fibers supplying the porcine urinary bladder wall.

E Lepiarczyk1, A Bossowska, J Kaleczyc, M Majewski.   

Abstract

Botulinum toxin (BTX) belongs to a family of neurotoxins which strongly influence the function of autonomic neurons supplying the urinary bladder. Accordingly, BTX has been used as an effective drug in experimental therapies of a range of neurogenic bladder disorders. However, there is no detailed information dealing with the influence of BTX on the morphological and chemical properties of nerve fibres supplying the urinary bladder wall. Therefore, the present study investigated, using double-labeling immunohistochemistry, the distribution, relative frequency and chemical coding of cholinergic and noradrenergic nerve fibers supplying the wall of the urinary bladder in normal female pigs (n = 6) and in the pigs (n = 6) after intravesical BTX injections. In the pigs injected with BTX, the number of adrenergic (DbetaH-positive) nerve fibers distributed in the bladder wall (urothelium, submucosa and muscle coat) was distinctly higher while the number of cholinergic (VAChT-positive) nerve terminals was lower than that found in the control animals. Moreover, the injections of BTX resulted in some changes dealing with the chemical coding of the adrenergic nerve fibers. In contrast to the normal pigs, in BTX injected animals the number of DbetaH/NPY- or DbetaH/CGRP-positive axons was higher in the muscle coat, and some fibres distributed in the urothelium and submucosa expressed immunoreactivity to CGRP. The results obtained suggest that the therapeutic effects of BTX on the urinary bladder might be dependent on changes in the distribution and chemical coding of nerve fibers supplying this organ.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21721400     DOI: 10.2478/v10181-011-0028-5

Source DB:  PubMed          Journal:  Pol J Vet Sci        ISSN: 1505-1773            Impact factor:   0.821


  6 in total

Review 1.  Intravesical treatments of bladder pain syndrome/interstitial cystitis.

Authors:  Jochen Neuhaus; Thilo Schwalenberg
Journal:  Nat Rev Urol       Date:  2012-11-27       Impact factor: 14.432

2.  Changes in chemical coding of sympathetic chain ganglia (SChG) neurons supplying porcine urinary bladder after botulinum toxin (BTX) treatment.

Authors:  E Lepiarczyk; A Bossowska; M Majewski
Journal:  Cell Tissue Res       Date:  2015-01-27       Impact factor: 5.249

3.  Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity.

Authors:  Andrzej Wróbel; Anna Serefko; Aleksandra Szopa; Ewa Poleszak
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

4.  The Influence of an Adrenergic Antagonist Guanethidine on the Distribution Pattern and Chemical Coding of Caudal Mesenteric Ganglion Perikarya and Their Axons Supplying the Porcine Bladder.

Authors:  Agnieszka Bossowska; Ewa Lepiarczyk; Paweł Janikiewicz; Barbara Wasilewska; Urszula Mazur; Włodzimierz Markiewicz; Mariusz Majewski
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

5.  Botulinum toxin type A induces changes in the chemical coding of substance P-immunoreactive dorsal root ganglia sensory neurons supplying the porcine urinary bladder.

Authors:  Agnieszka Bossowska; Ewa Lepiarczyk; Urszula Mazur; Paweł Janikiewicz; Włodzimierz Markiewicz
Journal:  Toxins (Basel)       Date:  2015-11-16       Impact factor: 4.546

6.  The Influence of Resiniferatoxin (RTX) and Tetrodotoxin (TTX) on the Distribution, Relative Frequency, and Chemical Coding of Noradrenergic and Cholinergic Nerve Fibers Supplying the Porcine Urinary Bladder Wall.

Authors:  Ewa Lepiarczyk; Agnieszka Bossowska; Jerzy Kaleczyc; Agnieszka Skowrońska; Marta Majewska; Michal Majewski; Mariusz Majewski
Journal:  Toxins (Basel)       Date:  2017-10-03       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.